Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murali Gopalakrishnan

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 28, 2012
SAR of α7 nicotinic receptor agonists derived from tilorone: exploration of a novel nicotinic pharmacophoreMichael R Schrimpf, Kevin B Sippy, Clark A Briggs, et al.
Assay and Drug Development Technologies|August 20, 2009
Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test stationJohn Malysz, Jens H Grønlien, Daniel B Timmermann, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2005
Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channelsKathleen H Mortell, David J Anderson, James J Lynch, et al.
Journal of Neuroimmunology|September 14, 2011
Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonistsJinhe Li, Suzanne L Mathieu, Richard Harris, et al.
Bioorganic & Medicinal Chemistry|March 31, 2004
Structure-activity studies for a novel series of tricyclic dihydropyridopyrazolones and dihydropyridoisoxazolones as K(ATP) channel openersIrene Drizin, Robert J Altenbach, Steven A Buckner, et al.
Brain Research|May 4, 2004
Differential action potentials and firing patterns in injured and uninjured small dorsal root ganglion neurons after nerve injuryXu-Feng Zhang, Chang Z Zhu, Rama Thimmapaya, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
The discovery of a new class of large-conductance Ca2+-activated K+ channel opener targeted for overactive bladder: synthesis and structure-activity relationships of 2-amino-4-azaindolesSean C Turner, William A Carroll, Tammie K White, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderArturo Perez-Medrano, Steven A Buckner, Michael J Coghlan, et al.
Journal of Medicinal Chemistry|October 4, 2011
Structure-activity studies of diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines as potent α4β2 nicotinic acetylcholine receptor ligandsMarc J C Scanio, Lei Shi, William H Bunnelle, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2010
In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's diseaseR Scott Bitner, William H Bunnelle, Michael W Decker, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|January 28, 2012
SAR of α7 nicotinic receptor agonists derived from tilorone: exploration of a novel nicotinic pharmacophoreMichael R Schrimpf, Kevin B Sippy, Clark A Briggs, et al.
Assay and Drug Development Technologies|August 20, 2009
Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test stationJohn Malysz, Jens H Grønlien, Daniel B Timmermann, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2005
Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channelsKathleen H Mortell, David J Anderson, James J Lynch, et al.
Journal of Neuroimmunology|September 14, 2011
Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonistsJinhe Li, Suzanne L Mathieu, Richard Harris, et al.
Bioorganic & Medicinal Chemistry|March 31, 2004
Structure-activity studies for a novel series of tricyclic dihydropyridopyrazolones and dihydropyridoisoxazolones as K(ATP) channel openersIrene Drizin, Robert J Altenbach, Steven A Buckner, et al.
Brain Research|May 4, 2004
Differential action potentials and firing patterns in injured and uninjured small dorsal root ganglion neurons after nerve injuryXu-Feng Zhang, Chang Z Zhu, Rama Thimmapaya, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
The discovery of a new class of large-conductance Ca2+-activated K+ channel opener targeted for overactive bladder: synthesis and structure-activity relationships of 2-amino-4-azaindolesSean C Turner, William A Carroll, Tammie K White, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderArturo Perez-Medrano, Steven A Buckner, Michael J Coghlan, et al.
Journal of Medicinal Chemistry|October 4, 2011
Structure-activity studies of diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines as potent α4β2 nicotinic acetylcholine receptor ligandsMarc J C Scanio, Lei Shi, William H Bunnelle, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2010
In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's diseaseR Scott Bitner, William H Bunnelle, Michael W Decker, et al.
Pageof 9